GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DERM · Sep 30, 2025

Journey Medical Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001104659-25-110457General Corporate
Debt relative to revenue73thOwn-history percentile · N=11
Evidence method

Level · gp.fundamentals.debt_to_revenue

147.78% · OPTIONAL · VALID

Operating cash generation50thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-14.00% · OPTIONAL · VALID

Revenue growth100thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

16.38% · CORE · VALID

Inventory pressure33thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

69.42% · OPTIONAL · VALID

Operating margin83thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

-8.98% · CORE · VALID

R&D intensity17thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

1.69% · OPTIONAL · VALID

SBC intensity75thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

10.89% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History16 statesHistory building
Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20246/8 normalizedLevel 3Dec 31, 20247/9 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
167.31%
Current
147.78%
Delta
-19.54%
Cash Generation Decreased
Previous
-6.28%
Current
-14.00%
Delta
-7.72%
Growth Increased
Previous
1.04%
Current
16.38%
Delta
15.34%
Inventory Pressure Decreased
Previous
85.63%
Current
69.42%
Delta
-16.21%
Profitability Increased
Previous
-19.16%
Current
-8.98%
Delta
10.18%
R And D Intensity Increased
Previous
0.00%
Current
1.69%
Delta
1.69%
Sbc Intensity Increased
Previous
8.90%
Current
10.89%
Delta
1.99%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · DERM Fundamental State →Transitioned To · DERM Fundamental State →Transitioned To · DERM BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · DERM CASH_GENERATION_DECREASED →Transitioned To · DERM GROWTH_INCREASED →Transitioned To · DERM INVENTORY_PRESSURE_DECREASED →Transitioned To · DERM PROFITABILITY_INCREASED →Transitioned To · DERM R_AND_D_INTENSITY_INCREASED →Transitioned To · DERM SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.